Old Web
English
Sign In
Acemap
>
authorDetail
>
L. von Boehmer
L. von Boehmer
Pathology
Antigen
Medicine
Oncology
Clinical endpoint
4
Papers
102
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Cancer testis antigen expression and immune responses by prostate cancer patients: Implications for prognosis and immunotherapy
2016
Journal of Clinical Oncology
L. von Boehmer
Peter Wild
Lukas F. Keller
Thomas Hermanns
Maurizio Provenzano
Giovanni Sais
Elke Jaeger
Frank Stenner
Holger Moch
A. Knuth
Show All
Source
Cite
Save
Citations (1)
Messenger RNA vaccination in NSCLC: Findings from a phase I/IIa clinical trial.
2011
Journal of Clinical Oncology
Martin Sebastian
L. von Boehmer
Alfred Zippelius
Frank Mayer
M. Reck
Djordje Atanackovic
Michael Thomas
Folker Schneller
Jan Stoehlmacher
Eray Goekkurt
Helga Bernhard
A. Groeschel
R Bals
S. Schmidt
Birgit Scheel
Sven Koch
Thomas Lander
Karl Josef Kallen
A. Knuth
Show All
Source
Cite
Save
Citations (20)
First-in-human trial focusing on the immunologic effects of the survivin-derived multiepitope vaccine EMD640744.
2011
Journal of Clinical Oncology
Stefanie Gross
Volker Lennerz
E. Gallerani
C. Sessa
Nicolas Mach
Steffen Boehm
Dagmar Hess
L. von Boehmer
A. Knuth
Adrian F. Ochsenbein
Ulrike Gnad-Vogt
Juergen Zieschang
Ulf Forssmann
Thomas Woelfel
Eckhart Kaempgen
Show All
Source
Cite
Save
Citations (1)
Particle size and activation threshold: a new dimension of danger signaling
2010
Blood
Lorna Rettig
S. P. Haen
A. G. Bittermann
L. von Boehmer
A. Curioni
Stefanie D. Krämer
A. Knuth
Steve Pascolo
Show All
Source
Cite
Save
Citations (80)
1